Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine - Cluster 1 - Health (Single stage - 2026) (HORIZON-HLTH-2026-01-TOOL-05).

Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

• The overall competitiveness of the EU biotechnology sector is strengthened through the further development of closer-to-deployment health innovations.
• The EU benefits from greater impact of the EU’s Research and Innovation (R&I) Framework Programmes through successful leveraging of previous EU funding in the field of regenerative medicine.
• EU innovators secure further funding to finalise the last stages of development.
• Patients benefit faster from solutions that improve their health and wellbeing.